MDeyes Once Daily is a high quality solution that simplifies AREDS 2 supplementation. “We are passionate about providing a precise, affordable AREDS 2 formula, that delivers the best possible outcomes for affected patients, including superior dosage compliance,” said Philip Spork, Director of MD EyeCare.
He said ‘Once daily’ dosing is best for compliance, but MDeyes goes further in sustaining long-term daily compliance with innovative compliance prompting packaging that has large, easy to read, calendar labeling on the blister foil to help patients track their daily dosage. “As Australia’s most affordable AREDS 2 product, cost-effective MDeyes also minimises patient dropout due to price.
“Outcomes are often limited by poor compliance, but with data showing patient compliance at 90 per cent* MDeyes Once Daily is a highly effective option for intermediate stage patients.”
Contact: (AUS) 1300 95 2001 or (NZ) 0800 443 652 or [email protected]
*90% of patients are each 80% compliant or higher.
